A61K 38/363
Fibrinogen
Official title: {Fibrinogen}
A61K38/363 (Fibrinogen) appears on 330 US grants and 607 published applications in this corpus.
Search patents in A61K- Granted patents
- 330
- Published applications
- 607
- Assignees
- 274
- Inventors
- 892
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 5 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 9 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 2 |
| 2002 | 4 | 7 |
| 2003 | 3 | 9 |
| 2004 | 3 | 15 |
| 2005 | 3 | 27 |
| 2006 | 6 | 24 |
| 2007 | 9 | 22 |
| 2008 | 6 | 26 |
| 2009 | 6 | 28 |
| 2010 | 10 | 23 |
| 2011 | 11 | 26 |
| 2012 | 12 | 26 |
| 2013 | 17 | 33 |
| 2014 | 18 | 28 |
| 2015 | 27 | 44 |
| 2016 | 19 | 42 |
| 2017 | 26 | 29 |
| 2018 | 15 | 24 |
| 2019 | 12 | 25 |
| 2020 | 13 | 22 |
| 2021 | 16 | 28 |
| 2022 | 14 | 22 |
| 2023 | 7 | 18 |
| 2024 | 14 | 25 |
| 2025 | 11 | 15 |
| 2026 | 8 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for kidney treatment using omentum, a medical kit for kidney treatment, including the same, and film for kidney treatment, including cured product thereof21 Jul 2026US 12,685,752 B2Rokit Healthcare Inc.
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals2 Jun 2026US 12,642,831 B2MangoGen Pharma, Inc.
- Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo5 May 2026US 12,616,720 B2RegenLab USA LLC
- Allogeneic human plasma and platelet derived products and uses thereof17 Mar 2026US 12,576,109 B2Consano Bio, Inc.
- Methods for isolating umbilical cord blood plasma products, tissue and cellular exosomes, and compositions and methods of use thereof17 Mar 2026US 12,576,201 B2Rutgers, The State University of New Jersey
- Use of mimetic peptide containing fibrinogen rgd motif in preparation of medications for preventing and/or treating parkinson's disease1 Oct 2026US 2026/0295017 A1Zhujiang Hospital, Southern Medical University
- Systems and methods for delivering drugs to retinal tissue10 Sep 2026US 2026/0263267 A1Clearside Biomedical, Inc.
- Synthesis and structure of high potency rna therapeutics10 Sep 2026US 2026/0265769 A1Arcturus Therapeutics, Inc.
- Use of a composition comprising a neo-synthesized extracelllar matrix for the treatment of cancer, in particular for the inhibition of cancer viability, migration, and proliferation6 Aug 2026US 2026/0224632 A1Novadip Biosciences
- Stabilized blood derived composition using antifibrinolytic agents23 Jul 2026US 2026/0207670 A1
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Medical implants and fibrosis-inducing agents330US 7,166,570 B2Angiotech International AG · 2007
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Fibrinogen-containing dry preparation, manufacture and use thereof225US 4,442,655 ASerapharm Michael Stroetmann · 1984
- Platelet glue wound sealant215US 5,733,545 AQuantic Biomedical Partners · 1998